Company intelligence
Epigenome Technologies
Single-cell & Bulk epigenetic services for histones, chromatin remodelers, transcription factors, RNA & DNA methylation
About Epigenome Technologies
We specialize in single-cell multi-omics technologies to study the epigenome in normal and disease states. Our proprietary technology, Paired-Tag, can simultaneously profile histone modification state and gene expression from up to a million single cells in parallel.
Verified activity
Signals from Epigenome Technologies
9 published signals
Research & Knowledge
Epigenome Technologies published an update on Epi-Allele, which elicits compensatory expression of non-targeted alleles and prevents haploinsufficiency in dominant genetic diseases.
Reported by Epigenome Technologies
Research & Knowledge
Epigenome Technologies published a study by Shi Chen, Xiangqi Meng, and Mong-Hong Lee in Cell Host & Microbe showing that a microbial chromatin remodeler drives gastric cancer progression and immune evasion by reprogramming the host epigenome.
Reported by Epigenome Technologies
Research & Knowledge
Epigenome Technologies published an article in Mol Cell by Kai Wucherpfennig and Piotr Sicinski (Dana-Farber Cancer Institute / Harvard Medical School) detailing how Cyclin E-CDK2 regulates cancer cell transcriptional programs and immunotherapy response through BRD4.
Reported by Epigenome Technologies
Research & Knowledge
Epigenome Technologies published a poster demonstrating the use of single-cell CUT&Tag and Droplet Paired-Tag to profile PBMCs and generate over 70,000 single-cell profiles.
Reported by Epigenome Technologies
Research & Knowledge
Epigenome Technologies published a study by Ariella Weinberg-Shukron and Anne Ferguson-Smith in Nat Commun about regulatory mechanisms of maternal imprinting at the murine Dlk1-Dio3 domain.
Reported by Epigenome Technologies
Research & Knowledge
Epigenome Technologies published an article in Nat Commun titled Reciprocal, methylation-dependent binding of Zfp57 and Gzf1 safeguards Dlk1-Dio3 imprinting during developmental reprogramming.
Reported by Epigenome Technologies
Research & Knowledge
Epigenome Technologies published a study in PNAS by Divyesh Joshi and Martin A. Schwartz in the field of epigenetics, focusing on Polycomb Repressive Complex 2 and vascular inflammation.
Reported by Epigenome Technologies
Products & Services
Epigenome Technologies offers an end-to-end Single-Cell Paired-Tag service as the first multiomic assay that captures RNA expression and epigenetic marks.
Reported by Epigenome Technologies
Research & Knowledge
Epigenome Technologies published a study by R. David Hawkins, Arnold Kriegstein, and Yin Shen in Nature regarding the 3D epigenome of glial cell types in developing human cortex.
Reported by Epigenome Technologies